Project Description
In the Press
Distinguished Fellow and Advisory Board Member Tim Greaney was quoted in the 5/3/2021 Wall Street Journal article “Blue Health Insurers Drop Revenue Rule That Limited Competition“:
The Blue Cross Blue Shield Association includes 35 insurers, each of which typically hold exclusive rights to the Blue Cross and Blue Shield brands within a certain territory, a setup that would remain intact under the antitrust settlement.
However, lifting the revenue cap could allow the Blue insurers to compete more against one another by expanding their non-Blue businesses, experts said. Dropping the limit “certainly should increase competition,” said Tim Greaney, a professor at the University of California Hastings College of the Law, though he said it isn’t clear how quickly it would have an effect.
…
One reason for the insurers to take action on the revenue rule might be to improve their position in the healthcare providers’ ongoing suit, by removing one practice that could be viewed as anticompetitive, Mr. Greaney said.
Source Sightings
A Step Forward for Health Care Market Oversight: Oregon Health Authority’s Health Care Market Oversight Program
Antitrust’s Healthcare Conundrum: Cross-Market Mergers and the Rise of System Power
Challenging Anticompetitive Cross-Market Health Mergers
American Bar Association 2022 Antitrust Fall Forum
The Rise Of Cross-Market Hospital Systems And Their Market Power In The US
Taming Health Insurance Costs for Employers and Employees